Mike

Our new systematic review and meta-analysis on the effectiveness and safety of antibiotics in treating people with chronic low back pain and Modic changes. Is it a good option? @jorspine #lowbackpain @WorldPhysio1951 @WorldSpineCare doi.org/10.1002/jsp2.1…

Can patients at risk for adjacent segment degeneration following ACDF be identified before even heading to the OR? link.springer.com/article/10.100… @DinoSamartzis @al_hornung @nbara44 @GMichaelMallow @EurSpineJournal

New publication addressing Bullying, Harassment and Discrimination of #musculoskeletal researchers! An initiative by the @OrsSpineSection. Let’s work together to make a change. @ORSsociety @ISSLS_Society @EurSpineJournal #ethics @SpinalNewsInt link.springer.com/article/10.100…

EXCITING stuff ! Check out our NEW study - "Oral Zoledronic acid bisphosphonate for the TREATMENT of chronic low #backpain with associated Modic changes: a pilot randomized controlled trial" onlinelibrary.wiley.com/doi/10.1002/jo… @JOrthopRes @OrsSpineSection @ORSsociety @jaro_karppinen #spine

Thank you all for your well wishes for our study and ISSLS Prize. A BIG THANK YOU to the special team behind this award: @GMichaelMallow, Zepeda, Kuzel, @nbara44, @khaledboushaala, Nolte, Espinoza, Oh, Colman, Kogan, @FrankPhillipsMD, Howard An @AOSpine @MOR_Docs @ISSLS_Society

Very proud of our @RushResearch spine team for being the recipients of the 2022 ISSLS Prize in Clinical Science! Amazing team work and dedication by all in addressing “Juvenile Modic Changes” and a step closer to understanding #backpain in kids. @ISSLS_Society @AmerAcadPeds